Here's when Meridian Bioscience investors will vote on firm's $1.53B acquisition
Meridian Bioscience has set a date for its shareholders to vote on a $1.53 billion acquisition deal involving two South Korea-based firms.
Meridian Bioscience has set a date for its shareholders to vote on a $1.53 billion acquisition deal involving two South Korea-based firms.